Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 12, 2018 6:00 pm

New Age Beverages Corp. (NASDAQ: NBEV) Starts Presentation at 30th Annual ROTH Conference

New Age Beverages (NASDAQ: NBEV) is a healthy functional beverage company that competes in the rapidly growing healthy functional beverage segments, including ready-to-drink (RTD) tea, RTD coffee, kombucha, energy drinks, relaxation drinks, coconut waters and functional waters. Since its creation, the company has become the 54th-largest beverage company and the eighth-largest healthy beverage company in the world. Its brands are sold throughout all 50 states and in more than 10 countries and include XingTea®, Marley One Drop®, Búcha® Live Kombucha, XingEnergy®, Marley Mellow Mood®, Marley Mate™, Coco-Libre®, and Aspen Pure® PH and Aspen Pure® Probiotic Water. For more information, visit…

Continue Reading

MondayMar 12, 2018 6:00 pm

Data I/O Corp. (NASDAQ: DAIO) Starts Presentation at 30th Annual ROTH Conference

Since 1972 Data I/O (NASDAQ: DAIO) has developed innovative solutions to enable the design and manufacture of electronic products for automotive, industrial/Internet-of-Things, consumer electronics, markets and their programming center and contract manufacturing partners. The company’s customers manufacture hundreds of millions of products each year using Data I/O programming solutions to reliably, securely, and cost-effectively deliver their Intellectual Property into programmable devices. Data I/O’s expertise in programmable integrated circuits, global supply chain processes, factory integration and IP management and protection are backed by a global network of Data I/O support and service providers to ensure customer success. For more information, visit…

Continue Reading

MondayMar 12, 2018 6:00 pm

Aimmune Therapeutics, Inc. (NASDAQ: AIMT) Starts Presentation at 30th Annual ROTH Conference

Aimmune Therapeutics (NASDAQ: AIMT) is a clinical-stage biopharmaceutical company developing treatments for potentially life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune’s first investigational biologic product using CODIT™, AR101 for the treatment of peanut allergy, has received the FDA’s Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4–17 years of age and is currently being evaluated in Phase 3 clinical trials. For more information, visit the company’s website at www.aimmune.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news…

Continue Reading

MondayMar 12, 2018 6:00 pm

Chaparral Energy, Inc. (CHPE) Starts Presentation at 30th Annual ROTH Conference

Chaparral (OTC: CHPE) is an independent oil and natural gas exploration and production company headquartered in Oklahoma City. Founded in 1988, Chaparral is a leading Mid-Continent operator with focused operations in Oklahoma’s highly economic STACK Play, where it has approximately 110,000 net acres and more than 3,500 potential drilling locations primarily in Kingfisher, Canadian and Garfield counties. The company has potential total production reserves of more than 1 billion barrels of oil equivalent and more than 350,000 net surface acres in the Mid-Continent region. For more information, visit the company’s website www.atchaparralenergy.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news…

Continue Reading

MondayMar 12, 2018 6:00 pm

Hydrogenics Corp. (NASDAQ: HYGS) Starts Presentation at 30th Annual ROTH Conference

Hydrogenics (NASDAQ: HYGS) is engaged in engineering and building the technologies required to enable the acceleration of a global power shift. Together with its subsidiaries, the company designs, develops and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. Headquartered in Mississauga, Ontario, the company provides hydrogen generation, energy storage and hydrogen power modules to its customers and partners around the world. Hydrogenics has manufacturing sites in Germany, Belgium and Canada and service centers in Russia, China, India, Europe, the US and Canada. For more information, visit the company’s website…

Continue Reading

MondayMar 12, 2018 6:00 pm

Hudson Technologies, Inc. (NASDAQ: HDSN) Starts Presentation at 30th Annual ROTH Conference

Hudson Technologies (NASDAQ: HDSN) provides innovative solutions to recurring problems within the refrigeration industry. Hudson’s proprietary RefrigerantSide® Services increase operating efficiency and energy savings, and remove moisture, oils and other contaminants frequently found in the refrigeration circuits of large comfort cooling and process refrigeration systems. Hudson also offers SMARTenergy OPS®, which is a cloud-based Managed Software as a Service for continuous monitoring, Fault Detection and Diagnostics and real-time optimization of chilled water plants. In addition, the company sells refrigerants and provides traditional reclamation services to the commercial and industrial air conditioning and refrigeration markets. For more information, visit the company’s…

Continue Reading

MondayMar 12, 2018 5:30 pm

Lannett Company, Inc. (NYSE: LCI) Starts Presentation at 30th Annual ROTH Conference

Lannett Company (NYSE: LCI) develops, manufactures, packages, markets and distributes generic versions of brand pharmaceutical products in the United States. It offers solid oral, extended release, topical, nasal and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel and injectable dosages. The company provides its products for various medical indications comprising glaucoma, muscle relaxant, migraine, anesthetic, congestive heart failure, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, dryness of the mouth, gout, hypertension and gallstone. For more information, visit the company’s website at www.lannett.com. About…

Continue Reading

MondayMar 12, 2018 5:30 pm

ACM Research, Inc. (NASDAQ: ACMR) Starts Presentation at 30th Annual ROTH Conference

ACM Research (NASDAQ: ACMR) develops wet processing technology and products for the semiconductor industry. Since being founded in 1998 in Silicon Valley, the company has produced equipment for a range of applications in IC manufacturing and wafer level packaging — with a special focus on cleaning technologies for advanced semiconductor devices. Semiconductor manufacturers can use the company’s single-wafer wet cleaning equipment in numerous manufacturing steps to remove particles, contaminants and other random defects, and thereby improve product yield, in fabricating advanced integrated circuits. For more information, visit the company's website at www.acmrcsh.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

Continue Reading

MondayMar 12, 2018 5:30 pm

Green Plains, Inc. (NASDAQ: GPRE) Starts Presentation at 30th Annual ROTH Conference

Green Plains (NASDAQ: GPRE) is a diversified commodity-processing business with operations related to ethanol production, grain handling and storage, cattle feedlots, food ingredients, and commodity marketing and logistics services. The company is the second largest consolidated owner of ethanol production facilities in the world, with 17 dry mill plants, producing nearly 1.5 billion gallons of ethanol at full capacity. In addition, the company owns a 62.5% limited partner interest and a 2.0% general partner interest in Green Plains Partners. For more information, visit the company’s website at www.gpreinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

Continue Reading

MondayMar 12, 2018 5:30 pm

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Starts Presentation at 30th Annual ROTH Conference

Galmed Pharmaceuticals (NASDAQ: GLMD) Is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of liver diseases. The company’s current developmental focus comprises Aramchol™, a first in class, novel, once-daily, oral therapy for the treatment of non-alcoholic steatohepatitis (“NASH”) for variable populations, as well as other liver associated disorders. Galmed is currently conducting the ARREST Study, a multicenter, randomized, double-blind, placebo-controlled phase 2b clinical study intended to evaluate the efficacy and safety of Aramchol™ in subjects with NASH, who are overweight or obese, and who are pre-diabetic or type-II-diabetic. For more information, visit the company’s website…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000